Company · CIK 0002022416 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq
Silexion Therapeutics Corp · SLXN
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 4, 2026 AForm 4 → | Jun 8, 4:06 pm EDT | Mitchell ShirvanCSO and CDO | 6,000 | — | — | 8,789 | — | |
| Jun 4, 2026 AForm 4 → | Jun 8, 4:05 pm EDT | Hadar Mirit HorenshteinCFO and Secretary | 7,500 | — | — | 12,515 | — | |
| Jun 4, 2026 AForm 4 → | Jun 8, 4:04 pm EDT | Ilan HadarChairman and CEO, Director | 10,000 | — | — | 16,547 | — |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.